Fakes, Michael G <br/><br/>
Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.  [electronic resource] 

 -  International journal of pharmaceutics  Mar 2009 
 - 167-74 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-3476 
<br/><br/><label>Standard No.: </label>10.1016/j.ijpharm.2008.11.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Biological Availability<br/>Chemistry, Pharmaceutical<br/>Chromatography, High Pressure Liquid<br/>Cross-Over Studies<br/>Dogs<br/>Drug Compounding--methods<br/>Drug Delivery Systems<br/>Drug Stability<br/>Female<br/>HIV Fusion Inhibitors--administration & dosage<br/>Humidity<br/>Indoles<br/>Nanoparticles<br/>Particle Size<br/>Phase Transition<br/>Piperazines--administration & dosage<br/>Povidone--chemistry<br/>Pyruvic Acid<br/>Solubility<br/>Technology, Pharmaceutical<br/>Temperature